2. ASIA 2 X 27
2. ASIA 2 X 27
Asia vulnerable to U.S.-style
accounting fiascos despite reforms
3. Spore 2 X 20
No quick relief for
fussy Singaporeans
4. Drug 3 X 20
Bristol-Myers, Merck
cases mark struggles
of drug industry
Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/2-asia-2-x-27-1447899208)
Originally published by The Jakarta Post